Art Unit 3778
Group 3770Medical and Surgical Instruments, Treatment Devices, and Supplies
- Active examiners
- 12
- Average office actions per grant
- 2.25
Grant ratio
- Art Unit 3778
- 64.8%
- Group 3770
- 61.2%
Active examiners
| Annette Dixon | 80.6% | 1.94 | August 2026 |
|---|---|---|---|
| Lynne Anderson | 70.4% | 2.25 | August 2026 |
| Kathryn E Ditmer | 56.6% | 2.26 | August 2026 |
| Joseph D Boecker | 75.7% | 1.65 | August 2026 |
| Bradley Philips | 71.8% | 2.16 | August 2026 |
| Elliot S Ruddie | 58.6% | 2.53 | July 2026 |
| Margaret M Luarca | 54.8% | 2.08 | August 2026 |
| Victoria Murphy | 62.2% | 3.01 | August 2026 |
| Mark Wardas | 15.6% | 2.57 | August 2026 |
| Joshua Lee | 70.0% | 1.67 | August 2026 |
| Andrew S. Lo | 61.1% | 1.54 | August 2026 |
| Nyca T. Nguyen | 100.0% | 1.74 | August 2026 |
Examiner distribution
- Median grant ratio
- 66.1%
- Middle 50% of grant ratios
- 57.1%–71.5%
- Median office actions / grant
- 2.20
- Middle 50% of office actions / grant
- 1.97–2.46
Active examiners with at least 20 applications.
Other associated examiners
Examiners without recent activity.
| Melanie J. Hand | 79.8% | 2.36 | November 2015 Appears inactive |
|---|---|---|---|
| Peter S. Vasat | 53.1% | 2.75 | May 2026 Potentially inactive |
| Paula L. Craig | 64.6% | 2.37 | August 2018 Appears inactive |
| Ned T. Heffner | 52.2% | 3.41 | March 2022 Appears inactive |
| Kristen Matter | 62.6% | 1.76 | April 2020 Appears inactive |
| Mark Wardas | 40.8% | 2.71 | August 2016 Appears inactive |
| Eric Bryant | 57.6% | 2.15 | April 2017 Appears inactive |
| Mark K. Han | 56.9% | 2.10 | November 2016 Appears inactive |
| Aundria Hairell | 52.6% | 2.28 | October 2015 Appears inactive |
| Jonathan Paciorek | 71.8% | 2.53 | October 2021 Appears inactive |
| Cana A Gallegos | 50.0% | 2.15 | November 2022 Appears inactive |
| Brian Marshall Booker | 0.0% | 1.89 | January 2020 Appears inactive |
| Ishan Tsay | 100.0% | 1.00 | June 2018 Appears inactive |
| Jennifer M. Deichl | 0.0% | 1.73 | May 2026 Potentially inactive |
Based on available public USPTO records; may be incomplete.